Micro-Nano Technology for Genomics and Proteomics BioMEMs - Ozkan
.pdfPEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
253 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
streptavidin-alkaline phosphatase |
combinatorial library (XXB1B2XX) |
|
|
|
and deconvolution libraries |
|
|
cAMP-dependent protein kinase |
combinatorial library (XXB1B2XX) |
|
|
|
and deconvolution libraries |
|
|
casein kinase I (CKI) or II (CKII) |
peptides derived from the |
SPOT |
[549] |
protein kinase C (PKC) catalytic |
phosphorylation sites RRASVA, |
|
|
subunit of protein kinase A (PKA) |
QKRPSQRAKYL, |
|
|
and γ 32P-ATP |
DDDDEESITRR, |
|
|
|
DDDSDDDAAAA |
|
|
potato acid phosphatase |
RRASS*VA, QKRPS*QRAKYL, |
|
|
|
DDDDEES*ITRR, |
|
|
|
DDDS*DDDAAAA (S* = |
|
|
|
phospho-serine) |
|
|
protein kinase A (PKA), protein kinase |
panel of human phosphorylation sites |
SPOT |
[550] |
C (PKC), casein kinase I (CKI), |
|
|
|
casein kinase II (CKII) and |
|
|
|
γ 32P-ATP |
|
|
|
125I-calmodulin |
phosphorylated and unphosphorylated |
SPOT |
[126] |
|
peptides derived from cell-cell |
|
|
|
adhesion molecule (C-CAM) |
|
|
|
isoforms S and L and single site |
|
|
|
substitution analogs |
|
|
porcine protein kinase C β and |
partial peptide scans of the C-CAM |
|
|
γ 32P-ATP |
isoforms S and L |
|
|
androgen receptor protein kinase and |
panel of kinase substrates known from |
SPOT |
[370] |
γ 32P-ATP |
literature |
|
|
enzyme I of bacterial sugar |
combinatorial library of the type |
SPOT |
[376] |
phosphotransferase system and |
XXXXXO1HO2XXXXX and |
|
|
32P-phosphoenolpyruvate |
iterative deconvolution libraries |
|
|
catalytic subunit of protein kinase A or |
combinatorial libraries of the type |
SPOT |
[540] |
cGMP activated protein kinase G |
XXXO1O2XXX and |
|
|
and γ 32P-ATP |
XXXRRO1O2X |
|
|
catalytic subunit of protein kinase A or |
combinatorial libraries of the type |
SPOT |
[115] |
cGMP activated protein kinase G |
O1KARKKSNO2, |
|
|
and γ 32P-ATP |
O1O2TQAKRKKSLA, |
|
|
|
O1O2KATQAKRKKSLA, |
|
|
|
TQAKRKKSLAO1O2, and |
|
|
|
TQAKRKKSLAMAO1O2 |
|
|
catalytic subunit of protein kinase A or |
combinatorial library of the type |
SPOT |
[116] |
cGMP activated protein kinase G |
XXXO1O2XXX and deconvolution |
|
|
and γ 32P-ATP |
libraries: XXXRKO1O2X, |
|
|
|
XRKKKO1O2X, O1RKKKKKO2, |
|
|
|
LRKKKKKHO1O2, and |
|
|
|
O1O2LRKKKKKH |
|
|
GST-Dyrk1A- (500–763) and |
partial substitutional analysis of |
SPOT |
[207] |
γ 32P-ATP |
RRRFRPASPLRGPPK |
|
|
maize Ca2+ -dependent protein kinase |
partial substitutional analysis of |
SPOT |
[334] |
(CDPK-1) and γ 32P-ATP |
LARLHSVRER |
|
|
protein kinase A (PKA), casein kinase |
kinase substrates Kemptide and Elk1; |
CLPP |
[338] |
II (CKII), p42-MAP kinase (Erk2) |
protein kinase inhibitor 2 |
|
|
and γ 32P-ATP |
|
|
|
(cont.)
254 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
||
|
|
|
|
||
p60c-src protein tyrosine kinase and |
Ttds-EEIYGEFF |
DIPP |
[143] |
||
γ 32P-ATP |
|
|
|
|
|
strepavidin-Cy3 conjugate; avidin-Cy5 |
biotin, HPYPP and WSHPQFEK |
|
|
||
conjugate |
|
|
|
|
|
anti-human insulin mab HB125 and |
biotin, wGeyidvk, pqrGstG, |
|
|
||
anti-mouse IgG-Cy5 conjugate |
WSHPQFEK and YGGFL |
|
|
||
WEHI-231 cells and negative control |
wGeyidvk |
|
|
||
cells |
|
|
|
|
|
Practical protocols to measure phosphorylation of peptides on peptide arrays |
SPOT |
[50] |
|||
prepared by SPOT synthesis exemplified by the kinase CKII |
|
|
|||
cyclic GMP-dependent protein kinase |
XXXRKB1B2X (deconvolution |
SPOT |
[117] |
||
(phosphorylation γ 32P-ATP) |
libraries described but data not |
|
|
||
|
|
|
shown) |
|
|
32P-labeled cyclic GMP-dependent |
B1RKKKKKB2 (preceding libraries |
|
|
||
protein kinase (binding) |
described but data not shown) |
|
|
||
GST-protein tyrosine phosphatase 1B; |
15-mer phospho-tyrosine-containing |
SPOT |
[140] |
||
mixture of anti-phospho-tyrosine |
peptides derived from human insulin |
|
|
||
antibodies, POD-conjugated |
receptor; degenerate SPOT library of |
|
|
||
anti-mouse antibody |
general structure AABX1ZX2BAA |
|
|
||
|
|
|
(Z = phospho-tyrosine, B = |
|
|
|
|
|
mixture of 20 natural amino acids, |
|
|
|
|
|
X defined amino acids) and peptides |
|
|
|
|
|
derived from human STAT 5A |
|
|
|
|
|
containing both phospho-tyrosine |
|
|
|
|
|
and phospho-threonine residues |
|
|
GST-protein tyrosine phosphatase ß; |
15-mer phospho-tyrosine-containing |
|
|
||
mixture of anti-phospho-tyrosine |
peptides derived from human Tie2 |
|
|
||
antibodies, POD-conjugated |
receptor containing additional |
|
|
||
anti-mouse antibody |
phospho-serine or |
|
|
||
|
|
|
phospho-threonine residues |
|
|
GST-fusion protein of substrate |
15-mer phospho-tyrosine-containing |
|
|
||
trapping mutant of protein tyrosine |
peptides derived from human insulin |
|
|
||
phosphatase 1B (D181A), |
receptor; degenerate SPOT library |
|
|
||
radioactively labeled by incubation |
of general structure |
|
|
||
kinase A in the |
AABX1ZX2BAAA (Z = |
|
|
||
with protein |
32 |
P-ATP |
|
|
|
presence of γ |
|
phospho-tyrosine, B = mixture of |
|
|
|
|
|
|
20 natural amino acids, X defined |
|
|
|
|
|
amino acids), progressive alanine |
|
|
|
|
|
substitution of |
|
|
|
|
|
MTRDIYETDYZRKGG ( Z = |
|
|
|
|
|
phospho-tyrosine), alanine scan of |
|
|
|
|
|
TRDIYETDYZRKGGKGL, |
|
|
|
|
|
substitutional analysis for X in |
|
|
|
|
|
MTRDIYETDXZRKGG ( Z = |
|
|
|
|
|
phospho-tyrosine) |
|
|
|
|
|
panel of known kinase substrates |
DIPP |
[218] |
c-Src substrate |
DIPP |
[219] |
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
255 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
p60 and FITC-labeled |
YIYGSFK, ALRRASLG, |
DIPP |
[310] |
anti-phospho-tyrosine antibody |
KGTGYIKTG and |
|
|
|
monophosphorylated derivatives |
|
|
PKA or p60 and FITC-labeled |
YIYGSFK, ALRRASLG, YIYGSFK |
DIPP |
[311] |
anti-phospho-tyrosine or |
and monophosphorylated |
|
|
anti-phospho-serine antibody |
derivatives |
|
|
NEK6 kinase and γ 32P-ATP |
human annotated phosphorylation |
DIPP |
[330] |
|
sites and mutational analysis of |
|
|
|
GLAKSFGSPNRAY |
|
|
Protein tyrosine kinase ABL and |
collection of 720 peptides (13-mers) |
DIPP |
[443] |
γ 32P-ATP or FITC-labeled |
derived from human annotated |
|
|
anti-phospho-tyrosine antibody |
phosphorylation sites (databases |
|
|
|
SwissProt and Phosphobase) |
|
|
GST-ERK-2 or GST-MEK-EE, |
double peptide synthesis of |
SPOT |
[141] |
anti-phospho-Elk-1 antibody, POD |
ELK1-substrate peptide |
|
|
labeled anti-rabbit antibody |
FWSTLSPIAPR, D-loop peptide |
|
|
|
KGRKPRDLELP and control |
|
|
|
peptide MNGGAANGRIL |
|
|
GST-fusion protein-protein tyrosine |
double peptide synthesized SPOTs |
|
|
phosphatase 1B; |
containing the PTP-1B substrate |
|
|
anti-phospho-tyrosine antibody, |
IYETDYZRKGG (Z = |
|
|
POD-conjugated anti-mouse |
phospho-tyrosine) and on the |
|
|
antibody |
second site a scan of 11-mers |
|
|
|
overlapping peptides derived from |
|
|
|
the cytoplasmic domain of insulin |
|
|
|
receptor |
|
|
GST-fusion protein of substrate |
double peptide synthesis of insulin |
|
|
trapping mutant of protein tyrosine |
receptor derived substrate peptide |
|
|
phosphatase 1B (D181A), |
IYETDYZRKGG (Z = |
|
|
radioactively labeled by incubation |
phospho-tyrosine) and binding |
|
|
with protein kinase A in the |
motif for YAP WW1 domain and |
|
|
presence of γ 32P-ATP |
p53 binding protein-2, respectively |
|
|
|
(YPPYPPPPYPS) |
|
|
PKA and Abl; Pro-Q Diamong |
Kemptide, p60 c-src (521-533), delta |
DIPP |
[350] |
phospho-specific stain or |
sleep inducing peptide (DSIP), |
|
|
FITC-labeled |
phosphoDSIP, CamKII peptide |
|
|
anti-phospho-tyrosine antibody for |
(GS1-10), different proteins |
|
|
detection |
|
|
|
GST-proteins of substrate trapping |
7 peptides (14-mers) derived from |
SPOT |
[397] |
mutants of tyrosine phosphatases |
human GHR together with the |
|
|
(PTP-H1, SAP-1, TC-PTP, |
appropriate |
|
|
PTP-1B) radioactively labeled by |
phospho-tyrosine-containing |
|
|
incubation with protein kinase A in |
derivatives |
|
|
the presence of γ 32P-ATP |
|
|
|
tyrosine kinase p60 c-scr and |
deletion, alanine scanning, positional |
DIPP |
[558] |
FITC-labeled |
scanningand full combinatorial |
|
|
anti-phospho-tyrosine antibody |
mixture libraries of |
|
|
|
CGG-YIYGSFK (p60 c-src |
|
|
substrate)
(cont.)
256 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology Reference |
|
|
|
phospho-specific antibodies MPM2, 3F3/2, PY20
GST fusions of GRB-SH2, SHP2-CSH2, GRB7-SH2, GRB 10-SH2 protein kinase A (PKA), Cdc 15
tyrosine kinase Abl and CKII together with FITC-labeled anti-phospho-tyrosine antibody and γ 32P-ATP, respectively
FITC-labeled anti-phospho-tyrosine antibody
tyrosine kinase Abl and γ 32P-ATP
kinases PDK1, Tie2, CKII, PKA GSK3 and γ 32P-ATP
Proteases chymotrysin, papain
trypsin
trypsin
porcine pancreatic elastase
trypsin; Escherichia coli outer membrane protease T (OmpT)
porcine pancreatic elastase
caspase-3
complete L-amino acid substitutional |
SPOT |
[477] |
analysis of AXXXX[pS/pT]XXXXA |
synthesis |
|
and AXXXX[pYT]XXXXA |
|
|
complete L-amino acid substitutional |
|
|
analysis of AXXXX[pYT]XXXXA |
|
|
complete L-amino acid substitutional |
|
|
analysis of |
|
|
AX1X1X1X1[S/T]X1X1X1X1A X = |
|
|
L-amino acids exept for Cys, X1 = |
|
|
L-amino Acids exept for Cys, Ser, |
|
|
Thr |
|
|
collection of more than 13 000 peptides |
DIPP |
[395] |
(13-mers) derived from human |
|
|
proteins |
|
|
2923 phosphopeptides (13-mers) |
|
|
derived from human proteins |
|
|
1433 randomly generated 15-mers |
DIPP |
[484] |
peptides |
|
|
peptide scans trough MBP and Tie2, |
DIPP |
[503] |
720 human annotated |
|
|
phosphorylation sites (13-mers |
|
|
peptides, 2923 phosphopeptides |
|
|
(13-mers) derived from human |
|
|
proteins, 1394 peptides derived from |
|
|
activation loops of human kinases |
|
|
combinatorial dipeptide libraries (400 |
SPOT |
[122] |
spots) for substrate identification |
|
|
substitution libraries GGRBG and |
SPOT |
[275] |
GGKBG (B = 20 amino acids) |
|
|
internally quenched libraries of the type |
SPOT |
[450] |
XXBXX and XXB1B2XX for |
|
|
substrate identification |
|
|
subsitutional analyses and truncation |
SPOT |
[206] |
analyses of a peptide derived from |
|
|
the 3rd domain of turkey ovomucoid |
|
|
inhibitor (inhibitor identification) |
|
|
internally quenched substitution analog |
SPOT |
[102] |
libraries of known substrates |
|
|
(substrate specificity mapping) |
|
|
combinatorial library of all 400 |
SPOT |
[295] |
dipeptide combinations |
|
|
(N-terminally labeled with FTC) |
|
|
from the genetically encoded amino |
|
|
acids |
|
|
complete L-amino acid substitutional |
SPOT |
[455] |
analysis of the caspase-3 substrate |
|
|
Abz-VDQMDGW (Abz = amino |
|
|
benzoic acid |
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
257 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
caspase-3 |
substitutional analysis of a known |
SPOT |
[457] |
|
substrate; protein sequence derived, |
|
|
|
combinatorial, positional scanning, |
|
|
|
and randomly generated peptide |
|
|
|
libraries (data not shown) for |
|
|
|
substrate identification |
|
|
cathepsin C and cathepsin L |
peptidic cathepsin inhibitors tethered to |
DIPP |
[596] |
|
fluorescence-labeled peptide nucleic |
|
|
|
acids |
|
|
elastase, cathepsin G |
partial peptide scan and substitution |
SPOT |
[254] |
|
analogs of the transferrin receptor |
|
|
|
stalk |
|
|
trypsin, granzyme B and thrombin |
Ac-LGPL-U, Ac-Nle-TPK-U, |
DIPP |
[486] |
|
Ac-IEPD-U and 361 variants of |
|
|
|
Ac-AOOK-U (Cys omitted); U = |
|
|
|
alkoxyamino-substituted coumarin |
|
|
|
derivative |
|
|
caspase 3, granzyme B, Jurkat cell |
peptide derivatives tethered to |
DIPP |
[597] |
lysates and granzyme B activated |
fluoresceine-labeled peptide nucleic |
|
|
apoptotic Jurkat cell lysates |
acids |
|
|
lysyl-endopeptidase (LEP), |
3 substrate peptides with LEP, |
|
[258] |
chymotrypsin, V8 protease; BSA |
chymotrypsin or V8 protease |
|
|
and ConA as negative controls; |
specificity |
|
|
TLCK and Boc-glu as inhibitors |
|
|
|
|
|
|
|
Isomerases |
|
|
|
human peptidyl-prolyl cis/trans |
peptide scan of human Cdc25C |
SPOT |
[336] |
isomerase Pin1, sequential |
including phosphorylated S/T-P |
|
|
electo-blotting to |
moieties |
|
|
PVDF-membranes, incubation of |
|
|
|
PVDV-membranes with anti-Pin1 |
|
|
|
antibody followed by secondary |
|
|
|
antibody |
|
|
|
Triggerfactor (TF) (Escherichia coli) |
peptide scans of E. coli proteins: EF-Tu |
SPOT |
[399] |
and TF-fragments |
(elongation factor Tu), MetE |
|
|
|
(methionine biosynthesis enzyme), |
|
|
|
ICDH (isocitrate dehydrogenase), |
|
|
|
GlnRS (glutamine-tRNA- |
|
|
synthetase), alkaline phosphatase, β-galactosidase, FtsZ (involved in cell division), GBP (galactose binding protein), L2 (a ribosomal protein), lambda cI, pro OmpA (pro-outer membrane protein A), sigma 32, SecA (involved in secretion) and murine DHFR (dehydrofolate reductase), yeast cytochrome B2, F1βand Su9-ATPase subunits, Photinus pyralis luciferase, RNaseT1 from
Aspergillus oryzae, and human PrP (prion protein)
(cont.)
258 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
Trigger Factor and DnaK from E. coli |
peptides derived from Trigger Factor |
SPOT |
[112] |
|
and DnaK substrate proteins |
|
|
|
|
|
|
Diverse Enzymes |
|
|
|
pertussis toxin (Bordetella pertussis) |
5 to 25-mer C-terminal peptides of the |
SPOT |
[576] |
and ATP + 32P-NAD: ADP |
G-Protein α-subunits of Gi3, Gi, Gs, |
|
|
ribosylation |
Go1, Go2, GoX1, Trod, Gz, Gq/11 and |
|
|
|
Gh, partial substitutional analysis of |
|
|
|
the 16-mer C-terminal peptide of the |
|
|
|
Gi 3α-subunit |
|
|
peptide detection by MALDI-TOF MS |
Ac-IYAAPKKKC-NH2 |
DIPP |
[532] |
concanavalin A (lectin binding) |
α-mannose |
|
|
β-1,4-galactosyltransferase |
N -acetylglucosamine |
|
|
galactosidase |
N -acetyllactosamine |
|
|
Rhodococcus rhodochrous epoxide |
5 substrates for the 4 hydrolases |
DIPP |
[616] |
hydrolase, Electrophorus electricus |
among them being 2 peptidic |
|
|
acetylcholine esterase, bovine |
substrates for trypsin and caspases |
|
|
pancreas trypsin, bovine intestinal |
|
|
|
mucosa alkaline phosphatase |
|
|
|
|
|
|
|
Applications of Peptide Arrays: Miscellaneous |
|
|
|
DNA Binding Peptides |
|
|
|
oligonucleotide with an endonuclease |
peptide scan of EcoRII and |
SPOT |
[465] |
EcoRII specific recgnition site |
substitutional analyses of selected |
|
|
|
peptides |
|
|
Practical protocols for the analysis of DNA-protein and DNA-peptide interactions |
SPOT |
[466] |
|
|
|
|
|
Metal Ion Binding Peptides |
|
|
|
anti-transforming growth factor (TGF) |
combinatorial libraries of the type |
SPOT |
[269] |
mab Tab2; silver(I); dsDNA |
XXB1B2XX and XB1XB2XX |
|
|
technetium–99m; nickel(II); |
combinatorial with 2 defined positions |
SPOT |
[270] |
anti-transforming growth factor α |
(linear, cyclic, L- and D- amino |
|
|
(TGFα) mab Tab2 |
acids) and deconvolution libraries |
|
|
technetium–99m |
combinatorial hexapeptide library |
SPOT |
[346] |
|
B1XB2XB3X (8000 peptide |
|
|
|
mixtures) and deconvolution |
|
|
|
libraries |
|
|
anti-transforming growth factor α |
substitutional analyses; combinatorial |
SPOT |
[494] |
(TGFα) mab Tab2; anti-p24 |
library of the type |
|
|
(HIV-1) mab CB4-1 |
XXXXB1B2B3XXXX; positional |
|
|
|
scanning combinatorial library |
|
|
lead(II); calcium(II); iron(III); |
combinatorial libraries of the type |
|
|
silver(I); nickel(II); technetium-99m |
XB1XB2XX; deconvolution |
|
|
|
libraries; positional scanning library |
|
|
anti-p53 mAb DO-1 |
peptides SDLHKL, DSLGKL, and |
LDPS |
[265] |
|
SGLHKL |
|
|
fluorescence shift following Pb2+ or |
dns(dansyl)-ECEE, dns-CCCC, |
|
|
As3+ binding |
dns-GGGG, dns-EEEE |
|
|
fluorescence shift following |
dns(dansyl)-ECEE, dns-CCCC, |
LDPS |
[172] |
Pb2+ binding |
dns-GGGG, dns-EEEE |
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
259 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
|
|
|
Arrays of 4 α-Helix Bundle Mini-Proteins |
|
|
|
|
FeIII-protoporphyrin IX |
libraries of antiparallel 4-α-helix |
SPOT |
[441] |
|
|
bundle hemoproteins |
|
|
copper(II), cobalt(II) |
libraries of antiparallel 4-α-helix |
SPOT |
[495] |
|
|
|
bundle metalloproteins |
|
|
|
|
|
||
|
Identification, Characterization, and Optimization of Peptidic Ligands |
|
|
|
anti-porcine tubulin-tyrosine ligase |
substitutional and truncation analysis |
SPOT |
[159] |
|
|
(TTL) mab 1D3 |
of a TTL-derived peptide; |
|
|
|
|
combinatorial library (XXB1B2XX) |
|
|
|
|
and deconvolution libraries |
|
|
streptavidin-alkaline phosphatase |
combinatorial library (XXB1B2XX) |
|
|
|
|
|
and deconvolution libraries |
|
|
cAMP-dependent protein kinase |
combinatorial library (XXB1B2XX) |
|
|
|
|
|
and deconvolution libraries |
|
|
streptavidin |
substitution analogs of Strep-tag II |
SPOT |
[493] |
|
amyloid β-peptide (Aβ) |
peptide scan of amyloid β-peptide |
SPOT |
[544] |
|
|
|
(Aβ); truncation analysis and |
|
|
|
|
alanine scan of a selected peptide |
|
|
amyloid β-peptide (Aβ); Aβ-derived |
peptide scans of amyloid β-peptide |
SPOT |
[545] |
|
|
peptide LBMP1620 |
(Aβ) and truncation analyses of |
|
|
|
|
selected peptides |
|
|
anti-cholera toxin mab TE33; anti-p24 |
D-amino acid substitutional analyses |
SPOT |
[274] |
|
|
(HIV-1) mab CB4-1 |
for the transformation of linear |
|
|
|
|
wt-epitopes into all-D peptide |
|
|
|
|
analogs |
|
|
strepavidin-FITC conjugate |
2888 O1O2-P/L-Q/F-F/L derived |
SODA |
[298] |
|
|
|
peptides bound to functionalized |
|
|
|
|
teflon membranes |
|
|
plasma-derived factor VIII (pdFVIII), |
dual position scanning library with the |
SPOT |
[12] |
|
|
recombinant factor VIII (rFVIII) |
sublibraries O1O2XXXXXX, |
|
|
|
|
XXO1O2XXXX, XXXXO1O2XX, |
|
|
|
|
XXXXXXO1O2; combination |
|
|
|
|
library of hits from the dual position |
|
|
|
|
sublibraries |
|
|
anti-p24 (HIV-1) mab CB4-1 |
libraries with all possible single step |
SPOT |
[212] |
|
|
|
transition pathways between 3 |
|
|
|
|
sequentially and structually |
|
|
|
|
unrelated mab CB4-1 binding |
|
|
|
|
peptides; substitutional analyses of |
|
|
|
|
peptides from selected transition |
|
|
|
|
pathways |
|
|
35S-labeled calmodulin |
mastpoparan |
SPOT |
[223] |
|
|
|
(Ac-INLKALAALAKKIL) and |
|
|
|
|
truncation and deletion analogs |
|
|
pIII phage display library of |
mastpoparan |
|
|
|
|
calmodulin variants |
(Ac-INLKALAALAKKIL) and |
|
|
|
|
truncation and deletion analogs |
|
|
(cont.)
260 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
pIII phage display scFv library |
partial peptide scan of the extracellular |
|
|
presenting the antibody repertoire of |
domain of the C3a receptor |
|
|
a mouse immunized with the |
|
|
|
recombinant extracellular domain of |
|
|
|
the C3a receptor |
|
|
|
FeIII-meso-tetrakis(4- |
alanine walk, partial substitutional |
SPOT |
[535] |
carboxyphenyl)porphyrin |
anlaysis, and truncation analysis of |
|
|
(FeIII-TCPP) |
an anti-porphyrin mab CDR-derived |
|
|
|
peptide |
|
|
biotinylated α-bungarotoxin (snake |
combinatorial 14-mer peptide library |
SPOT |
[57] |
neurotoxin) |
with 5 invariant, 4 partially variant |
|
|
|
and 5 totally variant positions |
|
|
plasma-derived factor VIII (pdFVIII), |
complete substitutional analyses of the |
|
[409] |
recombinant factor VIII (rFVIII) |
factor VIII binding peptide |
|
|
|
EYKSWEYC |
|
|
125I vascular endothelial growth factor |
complete D-amino acid substitutional |
SPOT |
[418] |
(VEGF) |
analyses of VEGF receptor |
|
|
|
II-derived peptides |
|
|
α-thrombin |
peptide scans of clones T10-11 and |
SPOT |
[439] |
|
T10-39 identified by mRNA display |
|
|
|
with α-thrombin as target; |
|
|
|
L-substitutional analyses of T10-11 |
|
|
|
and T10-39 |
|
|
|
|
|
|
Chemical Transformations |
|
|
|
Dpab-Ala-O-FM = Methyl Red |
combinatorial libraries of all possible |
SPOT |
[538] |
(2{[4-(dimethylamino)phanyl]azo} |
dipeptide combinations |
|
|
benzoic acid)-labeled alanine |
|
|
|
α-formylmethyl (FM) ester |
|
|
|
aldehydes for the evaluation of |
|
|
|
amide chemical ligation strategies |
|
|
|
combinatorial dipeptide libraries were used to elucidate the reactivity of the |
SPOT |
[377] |
|
amino termini and amino acid side chains to be non-enzymatically modified by |
|
|
|
reducing sugars leading to advanced glycation end products (AGEs) or |
|
|
|
crosslinked by BSA-AGE |
|
|
|
|
|
|
|
Cell Binding to Peptide Arrays |
|
|
|
p60c-src protein tyrosine kinase and |
Ttds-EEIYGEFF |
DIPP |
[143] |
γ 32P-ATP |
|
|
|
strepavidin-Cy3 conjugate; avidin-Cy5 |
biotin, HPYPP, and WSHPQFEK |
|
|
conjugate |
|
|
|
anti-human insulin mab HB125 and |
biotin, wGeyidvk, pqrGstG, |
|
|
anti-mouse IgG-Cy5 conjugate |
WSHPQFEK, and YGGFL |
|
|
WEHI-231 cells and negative control |
wGeyidvk |
|
|
cells |
|
|
|
3T3 fibroblasts |
Gly-Arg-Gly-Asp-Ser |
DIPP |
[609] |
Review for therapeutic cancer targeting peptides including a short peptide |
DIPP |
[8] |
|
microarray section and experimental data of an array with 42 different peptides |
|
|
|
that was probed with Jurkat T-lymphoma cells |
|
|
PEPTIDE ARRAYS IN PROTEOMICS AND DRUG DISCOVERY |
261 |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
|
|
|
T-cell Epitope Mapping |
|
|
|
HLA-DR1 and HLA-DR4 molecules, |
partial peptide scans of the merozoite |
SPOT |
[163] |
|
|
HLA-DR4 binding self peptide as |
surface glycoprotein 1 (MSP1) of |
|
|
|
competitor, malaria-infected human |
plasmodium falciparum |
|
|
|
serum |
|
|
|
9C5.D8-H T-cell hybridoma |
peptide scan of rabies virus |
SPOT |
[394] |
|
|
|
nucleoprotein |
|
|
Identification of protein-protein interaction partners
35S-Met-labeled protein extract from Jukat cells containing the novel WD-repeat protein FAN
syntrophin PDZ domain
cell lysates from erythropoietin stimulated and unstimulated cells; JAK2, SHP1, PLCγ
human Yes-associated protein (hYAP) WW domain, rFE65 WW domain, and mMena EVH1 domain displayed on phage
peptide scans of the TNFR-R55 |
SPOT |
[2] |
cytoplasmic domain |
|
|
library of C-terminal peptides from all |
SPOT |
[211] |
known human proteins (3514 spots); |
|
|
substitutional analysis of a selected |
|
|
peptide |
|
|
peptide scan of the intracellular |
SPOT |
[278] |
domain of the EPO receptor |
|
|
peptide ligands for hYAP WW |
SPOT |
[42] |
(GTPPPPYTVG), rFE65 WW |
|
|
(PPPPPPPLPAPPPQP), and mMena EVH1 (SFEFPPPPTDEELRL) domains; negative control peptide
Peptidomimetics |
|
|
|
synthesis of peptide nucleic acid (PNA) oligomer arrays on polymer membranes |
SPOT |
[583] |
|
and their hybridisation with DNA probes |
|
|
|
simutaneous synthesis of peptides, peptomers and peptoids on continuous |
SPOT |
[16] |
|
surfaces; amino funtionalization of cellulose membranes with epibromohydrin |
|
|
|
and 4,7,10-trioxa-1,13-tridecanediamine |
|
|
|
fluorescent-labeled model DNA |
peptide nucleic acid (PNA) oligomer |
SPOT |
[355] |
oligonucletide |
arrays on cellulose, polypropylene |
|
|
|
and PTFE membranes with different |
|
|
|
spacer molecules |
|
|
anti-transforming growth factor α |
amino and amino-oxy-substituted |
SPOT |
[488] |
(TGFα) mab Tab2 |
1,3,5-triazine arrays (detailed |
|
|
|
synthesis protocols |
|
|
Synthesis of 1,3,5-triazines on continuous surfaces |
SPOT |
[489] |
|
synthesis of 1,3,5-trisubstituted hydantoin arrays on cellulose membranes |
SPOT |
[201] |
|
anti-transforming growth factor α |
peptoidic building block substitutional |
SPOT |
[456] |
(TGFα) mab Tab2 |
analyses of the mab Tab2 peptide |
|
|
|
epitope VVSHFND and of |
|
|
|
peptomers and peptoids derived |
|
|
|
thereof |
|
|
Synthesis of macrocyclic peptidomimetics which incorporate heteroaromatic |
SPOT |
[490] |
|
building blocks such as 2,4,6-trichloro-[1,3,5]triazine, |
|
|
|
2,4,6-trichloropyrimidine, 4,6-dichloro-5-nitropyrimidine, |
|
|
|
2,6,8-tricloro-7-methylpurine |
|
|
|
anti-transforming growth factor α |
randomly generated library of 8000 |
SPOT |
[202] |
(TGFα) mab Tab2 |
hexapeptoids and -peptomers |
|
|
(cont.)
262 |
ULRICH REINEKE, JENS SCHNEIDER-MERGENER AND MIKE SCHUTKOWSKI |
TABLE 7.4. Continued
Screening Molecule |
Library |
Technology |
Reference |
|
|
|
|
VASP-EVH1 domain GST fusion |
peptoid building block substitutional |
SPOT |
[617] |
protein |
analysis of a VASP-EVH1 peptide |
|
|
|
ligand; combinatorial peptoid |
|
|
|
building block library of two |
|
|
|
positions within a VASP-EVH1 |
|
|
|
peptide ligand |
|
|
|
|
|
|
Review Articles |
|
|
|
Description of the SPOT method in the context of other combinatorial library |
SPOT |
[157] |
|
techniques: practical approaches, library types, binding assays with |
|
|
|
anti-porcine tubulin-tyrosine ligase (TTL) mab 1D3 |
|
|
|
Different types of combinatorial peptide libraries are described: XB1XB2XX |
SPOT |
[494] |
|
(400 spots), XXXXB1B2B3XXXX (8.000 spots) and a positional scanning |
|
|
|
combinatorial library XXXX(3B3X)XXXX (68.000 spots) as well as |
|
|
|
deconvolution libraries and substitutional analyses. These libraries were |
|
|
|
applied for the identification of linear antibody epitopes (anti-TGFα mab Tab2 |
|
|
|
and anti-p24 (HIV-1) mab CB4-1) and metal ion binding peptides. |
|
|
|
Review describing the technology and applications of peptides on pins, |
Diff. |
[422] |
|
macroscopic DNA arrays, light-directed synthesis (DNA and peptides), |
|
|
|
peptides on paper (SPOTmethod), and inorganic combinatorial libraries |
|
|
|
Solid-Phase synthesis on planar supports including synthesis on glass, cellulose, |
Diff. |
[298] |
|
cotton, and teflon membrane supports) |
|
|
|
Personal comments on “classical” papers in combinatorial chemistry (e.g., R. |
Diff. |
[299] |
|
Frank on SPOT synthesis) |
|
|
|
Describes the mapping of linear and discontinuous interactions of |
SPOT |
[447] |
|
antibody/antigen and protein/protein complexes using sequence-derived |
|
|
|
peptide scans, substitutional analyses and combinatorial libraries prepared by |
|
|
|
SPOT synthesis |
|
|
|
Mapping of linear epitopes of 2 anti-interleukin-10 (IL-10) mabs with peptide |
|
|
|
scans and substitutional analyses, mapping of the IL-10/IL-10R interaction |
|
|
|
with peptide scans, identification of the anti-TGFα mab Tab2 by combinatorial |
|
|
|
hexapeptide libraries, identification of the anti-p24 (HIV-1) mab CB4-1 with a |
|
|
|
positional scanning combinatorial library |
|
|
|
Summary of the SPOT synthesis technique particularly addressing small |
SPOT |
[53] |
|
molecule and peptidomimetic arrays |
|
|
|
Review article describing peptide and protein arrays |
Diff. |
[133] |
|
Synthesis and application of peptide and peptidomimetic/small molecule arrays |
SPOT |
[179] |
|
prepared by SPOT synthesis; brief description of peptide library types |
|
|
|
Extensive review describing polymeric solid supports for SPOT synthesis |
SPOT |
[592] |
|
(cellulose and polypropylene) amino functionalization of membrane suports, |
|
|
|
linker systems |
|
|
|
peptide synthesis on solid supports, examples for product quality, |
|
|
|
compatibility of polymer membranes for peptide-antibody binding assays (p24 |
|
|
|
(HIV-1) mab CB4-1 and anti-interleukin-10 mab CB/RS/3), |
|
|
|
biological screening (types of peptide libraries, mapping of antibody epitopes and |
|
|
|
protein-protein interactions, enzymatic modification of cellulose-bound |
|
|
|
peptides, DNA and metal binding peptides, T-cell epitope mapping, and |
|
|
|
cellular assays) |
|
|
|
Detailed experimental assay protocols for the mapping of linear and |
SPOT |
[453] |
|
discontinuous antibody epitopes and protein-protein interactions |
|
|